Sort
48,018 grants matching “immunotherapy”
Host-tumor cell interaction in myeloma: therapeutic applications
$2,056,275Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Molecular Mechanisms of Blood Cell Transfusion
$2,055,702Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2011 · HL
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
$2,055,632Haian Fu · Emory University · P01 · FY2024 · CA
Immunologic Approaches to Ovarian Cancer
$2,052,807David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
SPORE in Brain Cancer
$2,051,421Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2022 · CA
SPORE in Brain Cancer
$2,051,421Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Molecular Mechanisms of Blood Cell Transfusion
$2,051,358Leslie Eric Silberstein · Boston Children'S Hospital · P01 · FY2012 · HL
TOPIC 405: INTRATUMORAL BIOSENSING FOR IN VIVO PHARMACOTYPING
$2,050,000Christian Knopke · Lodestone Biomedical, Llc · N44 · FY2022 · CA
Genetic Approaches to Cancer Immunotherapy
$2,049,200Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
SPORE in Lymphoma
$2,048,062Helen E Heslop · Baylor College Of Medicine · P50 · FY2023 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$2,048,056Michael A Caligiuri · Ohio State University · P01 · FY2015 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$2,048,056Michael A Caligiuri · Ohio State University · P01 · FY2016 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$2,047,755Case Western Reserve University · U01 · FY2003 · AI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,046,999Roy S Herbst · Yale University · P50 · FY2022 · CA
METABOLIC REPROGRAMMING OF THE IMMUNOSUPPRESSIVE MYELOID NICHE IN SOFT TISSUE SARCOMA AS A MEANS OF ENHANCING IMMUNOTHERAPY
$2,046,875The Johns Hopkins University · · FY2022 · Department of the Army
UCLA SPORE in Brain Cancer
$2,046,459Linda M Liau · University Of California Los Angeles · P50 · FY2022 · CA
UCLA SPORE in Brain Cancer
$2,046,404Linda M Liau · University Of California Los Angeles · P50 · FY2023 · CA
Targeted antigen receptor treatment of cancer
$2,046,251Sloan-Kettering Institute For Cancer Res · P01 · FY2005 · CA
T cell effector and regulatory mechanisms in asthma and food allergy
$2,045,480Andrew D Luster · Massachusetts General Hospital · U19 · FY2014 · AI
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$2,044,559Michael A Caligiuri · Ohio State University · P01 · FY2009 · CA
VICKtOrY Early Clinical Trials Consortium
$2,044,455Patricia M Lorusso · Yale University · UM1 · FY2023 · CA
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2023 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2019 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2022 · AI
Impact of Immunotherapy on Viral Immunity in Humans
$2,043,956Raymond T Chung · Massachusetts General Hospital · U19 · FY2020 · AI